Real-world data comparison of time to next treatment for patients with HER2 low metastatic treated with either chemotherapy or fam-trastuzumab deruxtecan-nxki following chemotherapy in the metastatic setting

被引：0
|
作者：
Gorantla, Vikram C.
Rui, Anna
Rosenfeld, Stephan B.
Kudrik, Fred J.
Vasudevan, Anupama
Sura, Teena
Gart, Mike
Kanovsky, Doug
Brenneman, Dawn
Varughese, Prateesh
Scott, Jeffrey A.
Choksi, Rushir J.
Geller, Robert B.
Blanc, Simon
机构：
[1] Univ Pittsburgh Med Ctr, Pittsburgh, PA USA
[2] Integra Connect PrecisionQ, W Palm Beach, FL USA
[3] Highlands Oncol Grp, Fayetteville, AR USA
[4] South Carolina Oncol Associates, W Columbia, SC USA
[5] Integra Connect, W Palm Beach, FL USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e13169
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Outcome with pertuzumab, docetaxel, and trastuzumab (PTH) regimen in patients with HER2 positive metastatic breast cancer: Real-world data from a single center in India.
    Gogia, Ajay
    Gupta, Anshul
    Batra, Atul
    Deo, S. V. S.
    Sharma, Daya Nand
    Mathur, Sandeep
    Mishra, Ashutosh
    Prasad, Chandra Prakash
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [42] The efficacy and safety of trastuzumab biosimilar HLX02 compared with reference trastuzumab plus pertuzumab in combination with chemotherapy as the first-line treatment for HER2 positive metastatic breast cancer: A real-world study in China.
    Yan, Ying
    Li, Huiping
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [43] REAL-WORLD DATA: IMPACT OF LOW HER-2 EXPRESSION IN METASTATIC HR+/HER2-BREAST CANCER TREATED WITH PALBOCICLIB
    Montenegro, Maria Alexandra
    Simao, Diana Cardoso
    Mendes, Jose Leao
    Fernandes, Leonor Raposo
    Martins, Maria Manuela
    Da Luz, Ricardo
    Oliveira, Sonia Duarte
    BREAST, 2023, 71 : S57 - S58
  • [44] Real-world study of palbociclib combined with endocrine therapy for patients with metastatic breast cancer: A comparison of subsequent treatment patterns and HER2 expression analysis
    Liang, Xu
    Zhang, Linhui
    Gui, Xinyu
    Di, Lijun
    Li, Huiping
    Song, Guohong
    CANCER, 2024, 130 : 1476 - 1487
  • [45] Comparative analysis of overall survival in patients with HER2-amplified treatment-refractory metastatic colorectal cancer treated with pertuzumab plus trastuzumab in Mypathway and patients treated in the real-world
    Yoshimoto, Takuya
    Narita, Yusuke
    Yuki, Miho
    Asakawa, Takashi
    Kawakami, Satoe
    Gower-Page, Craig
    Reyes-Rivera, Irmarie
    Patel, Arisha
    Nakamura, Yoshiaki
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (04)
  • [46] Clinical Characteristics and Prognosis of HER2-0 and HER2-Low-Positive Breast Cancer Patients: Real-World Data from Patients Treated with Neoadjuvant Chemotherapy
    Poeschke, Patrik
    Fasching, Peter A.
    Adler, Werner
    Ruebner, Matthias
    Beckmann, Matthias W.
    Hack, Carolin C.
    Heindl, Felix
    Hartmann, Arndt
    Erber, Ramona
    Gass, Paul
    CANCERS, 2023, 15 (19)
  • [47] Evaluation of real-world treatment outcomes in patients with distant metastatic Merkel cell carcinoma following second-line chemotherapy in Europe
    Becker, Juergen C.
    Lorenz, Eva
    Ugurel, Selma
    Eigentler, Thomas K.
    Kiecker, Felix
    Pfoehler, Claudia
    Kellner, Ivonne
    Meier, Friedegund
    Kaehler, Katharina
    Mohr, Peter
    Berking, Carola
    Haas, Gabriele
    Helwig, Christoph
    Oksen, Dina
    Schadendorf, Dirk
    Mahnkel, Lisa
    Bharmal, Murtuza
    ONCOTARGET, 2017, 8 (45) : 79731 - 79741
  • [48] Real-world clinical outcomes in patients (pts) with HR+/HER2-metastatic breast cancer (mBC) treated with chemotherapy (CT) in the United States (US)
    Tolaney, Sara M.
    Punie, Kevin
    Kurian, Allison W.
    Ntalla, Ioanna
    Verret, Wendy
    Sadetsky, Natalia
    Sjekloca, Nikoleta
    Stokes, Michael
    Jhaveri, Komal L.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [49] Comparison of real-world mortality data among patients with glioblastoma (GBM) and metastatic pancreatic cancer (mPC) treated in the community oncology setting
    Cosgrove, David
    Aguilar, Kathleen
    Wang, Yunfei
    Sykes, Charles
    Reinwald, Sarah
    Kubisiak, Emily
    Su, Zhaohui
    Chandrasekaran, Vasu
    Stees, Larisa
    Iyer, Rupa
    Robert, Nicholas J.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [50] Real-world treatment with abiraterone acetate in metastatic castration-resistant prostate cancer (mCRPC) patients in the post-chemotherapy setting in Europe
    Dearden, L.
    Musingarimi, P.
    Shalet, N.
    Demuth, D.
    Alvarez, L. Garcia
    Muthutantri, A.
    Venerus, A.
    Lasry, R.
    Hankins, M.
    Maher, T.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S490 - S491
12345